Neo-polycin

   
Google
 
Web NewDrugInformation.com

Neo-polycin


Drug - Neo-polycin
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate
Multiple ingredients are in alphabetical order.

Strength - 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
The potency of the active ingredient(s), Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate. May repeat for multiple part products.

Applicant - DOW PHARM
The firm name holding legal responsibility for Neo-polycin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 060427
The FDA assigned number to Neo-polycin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Neo-polycin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Neo-polycin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Neo-polycin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Neo-polycin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Dow Pharmaceutical Corp Sub Dow Chemical Co
The full name of the firm holding legal responsibility for the new application of Neo-polycin.

Neo-polycin


Neomycin Sulfate And Polymyxin B Sulfate Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neo-polycin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Follutein 10,000 Units/vial Injectable; Injection
Pregnyl 10,000 Units/vial Injectable; Injection
Zoladex Eq 10.8mg Base Implant; Implantation
Zoladex Eq 3.6mg Base Implant; Implantation
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic

NewDrugInformation